Proto Labs Inc (PRLB) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — PRLB

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	127.92	123.97	104.42	90.38	82.69	87.87	96.15	92.80	83.50	66.49	62.05	59.36	54.67	57.24	47.80	41.91	43.77
Short-term Investments	14.86	12.31	14.82	12.80	14.15	12.64	16.79	16.88	19.20	19.95	22.85	25.25	24.38	19.91	16.54	18.34	19.59
Accounts Receivable	95.07	85.55	77.79	78.01	73.90	69.46	70.89	77.85	78.40	75.03	77.62	80.61	82.47	85.96	85.63	83.47	74.67
Inventory	15.41	14.87	14.07	13.17	13.20	12.42	12.36	12.82	13.80	14.31	14.27	14.62	15.05	14.23	9.81	9.11	9.92
Total Current Assets	266.24	248.58	225.79	205.51	194.41	193.07	207.62	210.42	204.51	185.15	188.72	192.36	190.68	188.21	172.12	167.51	158.52
Property, Plant & Equipment	208.33	209.46	211.33	215.78	221.21	237.94	243.71	247.80	243.02	248.61	253.62	259.86	260.63	270.95	283.02	288.50	279.90
Goodwill	273.99	273.99	273.99	273.99	273.99	273.99	273.99	273.99	273.99	273.99	273.99	383.56	390.35	398.32	404.24	407.19	399.43
Intangible Assets	16.61	17.53	19.54	20.50	20.78	22.89	23.43	24.41	26.67	28.35	29.87	31.91	34.03	36.23	39.82	41.67	46.88
Total Non-current Assets*	525.05	529.99	531.06	537.75	543.04	560.71	550.58	559.38	579.73	592.06	602.66	714.58	727.97	746.54	758.19	781.78	775.93
Total Assets	791.30	778.57	756.86	743.25	737.45	753.79	758.21	769.80	784.25	777.21	791.37	906.94	918.65	934.75	930.31	949.29	934.45
Accounts Payable	21.54	19.63	17.39	15.58	16.29	15.00	15.91	15.26	17.92	16.47	19.85	16.89	15.64	17.51	22.74	26.04	21.85
Total Current Liabilities	73.20	70.72	69.74	62.16	62.09	53.76	50.95	58.44	74.63	66.22	78.38	60.72	58.92	60.25	56.06	62.42	59.85
Total Non-current Liabilities*	26.36	24.72	22.39	16.38	18.56	20.04	22.02	24.06	24.70	28.30	29.86	35.37	39.03	42.47	49.63	54.90	61.17
Total Liabilities	99.57	95.44	92.14	78.55	80.65	73.79	72.97	82.49	99.32	94.53	108.24	96.09	97.95	102.72	105.69	117.31	121.02
Retained Earnings	254.33	248.88	238.57	239.34	236.55	252.80	253.24	253.41	251.28	246.93	251.42	380.74	381.08	381.83	373.15	378.47	366.61
Total Stockholder Equity	691.73	683.13	664.72	664.71	656.80	679.99	685.24	687.31	684.92	682.69	683.14	810.85	820.70	832.04	824.62	831.98	813.43

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	149.34	139.34	136.49	135.37	135.06	126.21	121.75	125.62	125.63	127.89	125.05	130.71	122.27	125.86	115.61	121.72	126.90	124.17	123.58	125.34
Cost of Revenue	80.00	75.74	76.12	74.07	75.29	70.51	69.79	68.39	69.08	70.42	69.24	71.42	69.14	72.08	67.00	68.09	69.48	68.36	68.17	70.02
Gross Profit	69.34	63.59	60.37	61.29	59.77	55.70	51.96	57.23	56.55	57.47	55.81	59.28	53.12	53.78	48.61	53.63	57.42	55.80	55.41	55.32
Research & Development	10.79	10.54	10.32	10.71	11.17	10.61	9.70	9.77	10.66	11.17	9.49	10.11	9.87	10.68	8.91	9.31	9.45	10.56	10.39	10.61
Selling, General & Admin	19.65	17.01	17.05	17.16	18.75	16.85	15.17	16.26	16.60	16.31	16.08	17.06	15.82	16.83	17.77	16.48	16.52	16.77	11.75	16.36
Total Operating Expenses	57.98	53.75	53.57	52.48	54.81	51.17	53.45	48.65	50.55	50.64	47.42	48.87	47.52	50.03	165.74	47.57	52.22	47.91	42.36	48.40
Operating Income	11.36	9.84	6.80	8.81	4.97	4.53	(1.49)	8.58	6.00	6.83	8.40	10.42	5.61	3.75	(117.13)	6.06	5.20	7.89	13.05	6.93
Pretax Income	12.60	11.32	8.15	10.25	6.67	5.99	(0.28)	9.87	7.36	7.73	9.94	10.74	2.24	5.04	(116.70)	6.03	5.20	7.59	12.93	7.06
Tax Provision	3.45	3.21	2.15	3.04	2.25	2.39	0.12	2.68	2.82	2.46	2.95	2.78	2.62	2.38	(1.64)	2.08	2.65	2.50	1.02	2.23
Net Income	9.15	8.11	6.00	7.22	4.43	3.60	(0.40)	7.19	4.54	5.27	6.99	7.95	(0.38)	2.66	(115.06)	3.95	2.56	5.10	11.91	4.84
Basic EPS	0.38	0.34	0.25	0.30	0.19	0.15	(0.02)	0.29	0.18	0.21	0.26	0.31	(0.01)	0.10	(4.19)	0.14	0.09	0.19	0.43	0.17
Diluted EPS	0.37	0.33	0.25	0.30	0.18	0.15	(0.01)	0.29	0.18	0.20	0.26	0.31	(0.01)	0.10	(4.19)	0.14	0.09	0.19	0.44	0.17

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	15.44	17.54	16.45	29.09	10.58	18.38	17.29	24.75	14.44	21.34	17.23	24.18	9.29	22.58	10.52	20.52	13.26	17.78	23.02	11.50
Capital Expenditures	6.20	3.54	8.05	4.06	1.47	1.26	0.83	1.56	4.20	2.59	18.18	3.11	3.39	3.44	5.27	10.38	2.96	3.07	6.25	4.03
Free Cash Flow*	9.24	14.00	8.40	25.03	9.12	17.12	16.46	23.20	10.25	18.75	(0.95)	21.07	5.90	19.14	5.24	10.14	10.30	14.71	16.76	7.47
Investing Cash Flow	(7.20)	(4.77)	(5.61)	(4.25)	(0.64)	(2.91)	(2.90)	(14.35)	(0.75)	4.42	(14.42)	2.06	3.43	4.38	0.27	(6.85)	(10.68)	(25.83)	3.66	6.76
Financing Cash Flow	(4.54)	0.66	(4.48)	(10.72)	(3.24)	(21.93)	(12.55)	(19.09)	(10.29)	(16.62)	(3.12)	(9.07)	(8.06)	(21.60)	(15.13)	(7.97)	(4.22)	(0.60)	(8.38)	(11.96)

* Derived from reported values